Unknown

Dataset Information

0

Comprehensive Analysis of Co-Mutations Identifies Cooperating Mechanisms of Tumorigenesis.


ABSTRACT: Somatic mutations are one of the most important factors in tumorigenesis and are the focus of most cancer-sequencing efforts. The co-occurrence of multiple mutations in one tumor has gained increasing attention as a means of identifying cooperating mutations or pathways that contribute to cancer. Using multi-omics, phenotypical, and clinical data from 29,559 cancer subjects and 1747 cancer cell lines covering 78 distinct cancer types, we show that co-mutations are associated with prognosis, drug sensitivity, and disparities in sex, age, and race. Some co-mutation combinations displayed stronger effects than their corresponding single mutations. For example, co-mutation TP53:KRAS in pancreatic adenocarcinoma is significantly associated with disease specific survival (hazard ratio = 2.87, adjusted p-value = 0.0003) and its prognostic predictive power is greater than either TP53 or KRAS as individually mutated genes. Functional analyses revealed that co-mutations with higher prognostic values have higher potential impact and cause greater dysregulation of gene expression. Furthermore, many of the prognostically significant co-mutations caused gains or losses of binding sequences of RNA binding proteins or micro RNAs with known cancer associations. Thus, detailed analyses of co-mutations can identify mechanisms that cooperate in tumorigenesis.

SUBMITTER: Jiang L 

PROVIDER: S-EPMC8774165 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3233530 | biostudies-literature
| S-EPMC4577832 | biostudies-literature
| S-EPMC4710200 | biostudies-literature
| S-EPMC5731952 | biostudies-literature
| S-EPMC8741038 | biostudies-literature
| S-EPMC5488945 | biostudies-literature
| S-EPMC4517500 | biostudies-literature
2021-12-13 | GSE184499 | GEO
| S-EPMC8988344 | biostudies-literature
| S-EPMC3023834 | biostudies-literature